News Focus
News Focus
icon url

ATLnsider

09/24/22 1:16 AM

#516464 RE: hyperopia #516462

This is a very good point hyperopia.
icon url

flipper44

09/24/22 1:56 AM

#516465 RE: hyperopia #516462

“13 or more years (biologics) from FDA approval”
icon url

exwannabe

09/24/22 5:49 AM

#516468 RE: hyperopia #516462

no2koolaid, are you aware that DCVax has “orphan drug designation” in the US? It will be exempt from the negotiation process under The Inflation Reduction Act, so this should not be an immediate concern for Northwest Bio or their shareholders.


True if and only if it is approved for nGBM only.

* Drugs that have received an “orphan drug” designation for only one rare disease or condition and the only approved indication(s) is for such disease or condition

icon url

no2koolaid

09/24/22 10:17 AM

#516497 RE: hyperopia #516462

hyperopia, I was not aware that the orphan drug designation would insulate them from the Act's price controls. I appreciate knowing that, thank you.